Trials / Unknown
UnknownNCT02299310
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effect of valsartan and perindopril on HOMA-IR Index in patients with chronic kidney disease.
Detailed description
eligiable volunteers are administrated single-dose over the period I and II (crossover) of Valsartan (80mg) as of Perindopril (4mg). Every time before and after each medication, HOMA-IR index and other parameters and safety of Valsartan (80mg) and Perindopril (4mg) is performed using a blood sample and conducting some tests (vital signs, physical exam, ECG, laboratory test, etc.) respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan | Valsartan 80mg/tablet, 1 tablet once daily (crossover) |
| DRUG | Perindopril | Perindopril 4mg/tablet, 1 tablet once daily (crossover) |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-11-01
- Completion
- 2015-12-01
- First posted
- 2014-11-24
- Last updated
- 2014-12-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02299310. Inclusion in this directory is not an endorsement.